Skip to main content

Table 2 The clinical features of the LAC specimens used in this study

From: SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma

  WHO grade
Feature I (n = 11) II (n = 73) III (n = 8)
Gender
 Male 7 38 6
 Female 4 35 2
Age at diagnosis
 <60 5 25 3
 ≥ 60 6 48 5
T stage
T1–2 11 54 4
T3–4 0 19 4
N stage
N0 9 34 4
N1–3 2 39 4
TNM stage
 I 8 25 2
 II 3 22 2
 III 0 26 4
Location
 Left 3 26 4
 Right 8 47 4